On Friday, Resmed Inc (RMD) stock saw a modest uptick, ending the day at $240 which represents a slight increase of $0.41 or 0.17% from the prior close of $239.59. The stock opened at $240.6 and ...

Fears that GLP-1 obesity drugs would reduce demand for ResMed’s various CPAP airflow machines have proven unfounded..

ResMed tends to opt for strategic buyouts to boost SaaS revenues. As of the fiscal fourth-quarter end, the SaaS business reflected strong contributions from the MEDIFOX DAN brand in Germany and growth ...

Bank of America Securities analyst Lyanne Harrison has reiterated their bullish stance on RMD stock, giving a Buy rating on October 10. Lyanne ...

Valued at $35.3 billion by market cap, San Diego, California-based ResMed Inc. (RMD) develops, manufactures, distributes, and ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Resmed (RMD – Research Report) and Abbott ...

On Tuesday, Resmed Inc (RMD) stock saw a decline, ending the day at $239.18 which represents a decrease of $-1.53 or -0.64% from the prior close of $240.71. The stock opened at $242.37 and touched a ...

ResMed's strong market share in sleep apnea treatments ... While RMD currently trades above its mean price target of $238.10, its Street-high target of $280 indicates an upswing of 16.4% from ...